Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. - Wikidata - wikimedia - TriplyDB

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.

http://www.wikidata.org/entity/Q45144618

about

Brain tumors Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs Functional brain imaging: an evidence-based analysis Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.Hypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme.Imaging biomarkers in primary brain tumours.Imaging in neurooncology Human gene therapy and imaging in neurological diseases.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.[11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.Imaging biomarkers of brain tumour margin and tumour invasion Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and Histopathology Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.Advances in neuro-oncology imaging.Positron emission tomography: clinical applications in oncology. Part 2.Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates From anatomical to biological target volumes: the role of PET in radiation treatment planning Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.The role of PET in target localization for radiotherapy treatment planning.Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.Diffuse brainstem gliomas in children: should we or shouldn't we biopsy?Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.Microfluidics for positron emission tomography probe development.Usefulness of FMISO-PET for glioma analysis.Novel positron emission tomography radiotracers in brain tumor imaging.

P2860

Q24605136-5C966262-1D3C-44BE-ACF0-3476FB081558 Q28082603-FF14F94E-D86F-4681-A8DB-ABE445B59DBD Q30573784-31A39B7B-5D07-4D09-B3C1-8F8FA21286AB Q30811922-E1486013-A3BD-46ED-96C6-EEC851E76D11 Q30834011-04C17534-1E3F-47F6-BC0F-1CEC3A1853CA Q30880129-309CBBF1-C454-48FE-B3D3-51D875AD7F7D Q30989939-DBC27F08-A3F4-462B-A2D4-30A7C6FA20EB Q31023442-22DDE493-8D47-4078-B66F-5C71060430FD Q33578187-84D8B49C-D51D-4FAB-8A95-720A086B0D52 Q33599162-2CA8FE97-A483-47EE-87E8-124CC1E083A9 Q33719890-EF7C903D-CC98-4CF3-A901-043EA4E6A0AA Q34136061-F1010B55-4856-486C-814E-A81FFF94B67D Q34203946-790A7771-0404-4D1E-AE69-EE655703A1C7 Q34203953-B94793EA-A53C-447E-B101-728A856759D2 Q34203960-D598F081-F37B-4606-8BAD-F352BCDFE2DA Q34533978-57B71CBB-A4A2-4180-8F84-B3E623D4B353 Q35679377-46C96A9A-BD20-426B-B007-832BE8A0413C Q35699156-7320F483-B2A0-45B9-AD17-76E96A9439B7 Q35788602-16A1448A-9AD8-4EE1-BB14-FC1B7373B29D Q35807945-C9C8989A-4D57-405A-86F8-73CBA3A3728B Q35821500-7C11F5E2-307E-4874-959C-52D8AB200A5F Q35835743-E9D20713-88F5-491B-ABC6-6C70080E235A Q35912078-050A2470-3ACF-4915-8136-F79C1F31246A Q36325371-DA5D5C57-AF5B-4B66-B9CC-2E76A86EDB9A Q36339461-BC8727A0-9C38-4546-AD88-57DE1A7CD923 Q36448703-502409E5-D186-4421-8077-C265CD8ED213 Q36644371-7CB5985C-AD4A-4205-90FE-58C3BBB5830C Q36657385-344848EC-1A48-4C2A-B610-89DC17EAF371 Q37037922-C58127C9-2596-4EC4-8CA8-50F25F664542 Q37082395-9A191A3E-D7C9-4E5C-BF00-F73E1C19DC4A Q37092483-16829ACA-4F7B-4D80-89DE-A7B0F7F709F2 Q37235829-F29D7E9F-8FE9-4ECC-8A30-1103A9CE217D Q37244302-7BCC967E-16E4-41CF-A4B8-0702B4DE702D Q37328146-520DD3C8-0D8C-4FCE-9525-E4A3E7DB81D9 Q37432387-85A823CC-2C4E-40EE-A461-DB15C065E955 Q37469178-42C2EC14-67AE-4E5C-835B-DDFD52823185 Q37614748-64A365B1-A523-4E29-A977-50C059D1F9F0 Q37774061-613B1FE8-639A-450E-BFBF-E798DA056FF1 Q38156537-6C5F07D8-7F4D-4182-ACA0-98E3224D12B1 Q38670632-E708ABFE-D463-44D0-99E8-37E182F6FEB1

P2860

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.

http://www.wikidata.org/entity/Q45144618

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Delineation of brain tumor ext ...... h stereotactic histopathology.

@en

Delineation of brain tumor ext ...... h stereotactic histopathology.

@nl

type

label

Delineation of brain tumor ext ...... h stereotactic histopathology.

@en

Delineation of brain tumor ext ...... h stereotactic histopathology.

@nl

prefLabel

Delineation of brain tumor ext ...... h stereotactic histopathology.

@en

Delineation of brain tumor ext ...... h stereotactic histopathology.

@nl

P1433

Q45144618-A040B4BE-3646-4928-B191-6D6E82F8C011

P1476

Q45144618-FFA82FAA-F727-459C-A3FA-768A9B9D21CE

P2093

Q45144618-0AEEF2E2-F9C9-4A31-A560-30F23E9FA655

Q45144618-14E7B69E-FEEB-4774-9916-75D73554FFF6

Q45144618-24643B94-493C-423A-AFD4-B6710F5F44EA

Q45144618-306BBDDC-882D-4BEC-98C0-43E25CC80956

Q45144618-36F2E43B-F992-4192-9E20-7ADB74EFF1FB

Q45144618-6FDCEB30-FD70-41F2-A4D1-5FFA34E14676

Q45144618-91C94EEC-64E0-4EE1-A8F7-C899EDC3CC7F

Q45144618-B5F0FD54-2596-40EB-AF7B-975057A3C6CF

Q45144618-DE51A9C7-76DC-4DF8-8488-FE9BA7FCDC84

P304

Q45144618-9D197C33-76B7-4894-A8B6-437B2D3EF519

P31

Q45144618-6160D884-E178-4B88-B161-950B6950062A

P356

Q45144618-D958B880-990A-4224-877E-02F144474A2F

P407

Q45144618-D7FFFA55-53BA-478E-AAB9-EE02918F5232

P433

Q45144618-19CA3F67-5603-46BD-A5BD-F318B21D993A

P478

Q45144618-5301DB01-7F14-4CB8-88CD-E0D5A1CF7D18

P577

Q45144618-326DA2B3-3C73-4747-A482-89E4AADF2A9A

P698

Q45144618-30494448-325F-496C-8FF2-0D8FB0B90544

P356

1078-0432.CCR-04-0262

P1433

Clinical Cancer Research

P1476

Delineation of brain tumor ext ...... h stereotactic histopathology.

@en

P2093

Andreas H Jacobs

http://www.w3.org/2001/XMLSchema#string

Hrvoje Miletic

http://www.w3.org/2001/XMLSchema#string

Johannes C Klein

http://www.w3.org/2001/XMLSchema#string

Jurgen Voges

http://www.w3.org/2001/XMLSchema#string

Karl Herholz

http://www.w3.org/2001/XMLSchema#string

Lutz W Kracht

http://www.w3.org/2001/XMLSchema#string

Moritz Hoevels

http://www.w3.org/2001/XMLSchema#string

Susanne Busch

http://www.w3.org/2001/XMLSchema#string

Wolf-D Heiss

http://www.w3.org/2001/XMLSchema#string

P304

7163-7170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-04-0262

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15534088

http://www.w3.org/2001/XMLSchema#string